

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein retention in ER lumen (GO:0006621) | 8.82998710 |
| 2 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 8.32102750 |
| 3 | transcytosis (GO:0045056) | 7.50124196 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 7.49277325 |
| 5 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.28105115 |
| 6 | regulation of cellular extravasation (GO:0002691) | 7.05149310 |
| 7 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.81086659 |
| 8 | cholesterol catabolic process (GO:0006707) | 5.63954230 |
| 9 | sterol catabolic process (GO:0016127) | 5.63954230 |
| 10 | negative regulation of digestive system process (GO:0060457) | 5.58152265 |
| 11 | fructose metabolic process (GO:0006000) | 5.25493580 |
| 12 | epoxygenase P450 pathway (GO:0019373) | 5.17949955 |
| 13 | cysteine metabolic process (GO:0006534) | 5.16973554 |
| 14 | lipoprotein transport (GO:0042953) | 5.16344582 |
| 15 | peptidyl-proline hydroxylation (GO:0019511) | 5.15820474 |
| 16 | regulation of bile acid biosynthetic process (GO:0070857) | 5.12247524 |
| 17 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.10391332 |
| 18 | positive regulation of pseudopodium assembly (GO:0031274) | 5.05836072 |
| 19 | cobalamin metabolic process (GO:0009235) | 5.00627692 |
| 20 | Golgi transport vesicle coating (GO:0048200) | 4.99294037 |
| 21 | COPI coating of Golgi vesicle (GO:0048205) | 4.99294037 |
| 22 | hormone catabolic process (GO:0042447) | 4.70160842 |
| 23 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.70143619 |
| 24 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.70143619 |
| 25 | endocrine process (GO:0050886) | 4.70143619 |
| 26 | digestive system process (GO:0022600) | 4.60687780 |
| 27 | regulation of cGMP biosynthetic process (GO:0030826) | 4.56780789 |
| 28 | regulation of pseudopodium assembly (GO:0031272) | 4.54623885 |
| 29 | positive regulation of respiratory burst (GO:0060267) | 4.54060465 |
| 30 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.53816951 |
| 31 | intestinal epithelial cell development (GO:0060576) | 4.49645113 |
| 32 | membrane lipid catabolic process (GO:0046466) | 4.48344162 |
| 33 | diacylglycerol metabolic process (GO:0046339) | 4.38091409 |
| 34 | regulation of systemic arterial blood pressure (GO:0003073) | 4.33409207 |
| 35 | regulation of autophagic vacuole assembly (GO:2000785) | 4.31911037 |
| 36 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.31668039 |
| 37 | proline biosynthetic process (GO:0006561) | 4.29905013 |
| 38 | glycolipid catabolic process (GO:0019377) | 4.28838400 |
| 39 | virion attachment to host cell (GO:0019062) | 4.24284749 |
| 40 | adhesion of symbiont to host cell (GO:0044650) | 4.24284749 |
| 41 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.18375928 |
| 42 | sterol transport (GO:0015918) | 4.18053460 |
| 43 | cholesterol transport (GO:0030301) | 4.18053460 |
| 44 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.13354170 |
| 45 | zinc ion transport (GO:0006829) | 4.11868671 |
| 46 | endocrine pancreas development (GO:0031018) | 4.08387306 |
| 47 | angiotensin maturation (GO:0002003) | 4.06530994 |
| 48 | regulation of phospholipase A2 activity (GO:0032429) | 4.05198237 |
| 49 | cellular modified amino acid catabolic process (GO:0042219) | 4.04887991 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.03332894 |
| 51 | urea cycle (GO:0000050) | 4.01968064 |
| 52 | ceramide catabolic process (GO:0046514) | 4.01180495 |
| 53 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.98890015 |
| 54 | regulation of vitamin metabolic process (GO:0030656) | 3.97906618 |
| 55 | homocysteine metabolic process (GO:0050667) | 3.97302517 |
| 56 | signal peptide processing (GO:0006465) | 3.95439301 |
| 57 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.93881024 |
| 58 | positive regulation of nuclease activity (GO:0032075) | 3.92822659 |
| 59 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.92082914 |
| 60 | protein maturation by protein folding (GO:0022417) | 3.90953184 |
| 61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.87896041 |
| 62 | drug metabolic process (GO:0017144) | 3.85174962 |
| 63 | protein hydroxylation (GO:0018126) | 3.81738563 |
| 64 | urea metabolic process (GO:0019627) | 3.80105270 |
| 65 | regulation of cGMP metabolic process (GO:0030823) | 3.77899306 |
| 66 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.77149154 |
| 67 | mitochondrial calcium ion transport (GO:0006851) | 3.77049404 |
| 68 | response to endoplasmic reticulum stress (GO:0034976) | 3.72272377 |
| 69 | COPII vesicle coating (GO:0048208) | 3.72212566 |
| 70 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.72167519 |
| 71 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.66373656 |
| 72 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.65520298 |
| 73 | 4-hydroxyproline metabolic process (GO:0019471) | 3.63437467 |
| 74 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.60931717 |
| 75 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.60931717 |
| 76 | glycosphingolipid catabolic process (GO:0046479) | 3.60328737 |
| 77 | regulation of triglyceride catabolic process (GO:0010896) | 3.58328769 |
| 78 | response to nitric oxide (GO:0071731) | 3.55490888 |
| 79 | peptide catabolic process (GO:0043171) | 3.54677980 |
| 80 | regulation of nuclease activity (GO:0032069) | 3.54387312 |
| 81 | adhesion of symbiont to host (GO:0044406) | 3.54305440 |
| 82 | vitamin A metabolic process (GO:0006776) | 3.53988334 |
| 83 | nitrogen cycle metabolic process (GO:0071941) | 3.53099601 |
| 84 | cellular response to unfolded protein (GO:0034620) | 3.52784865 |
| 85 | uronic acid metabolic process (GO:0006063) | 3.52074197 |
| 86 | glucuronate metabolic process (GO:0019585) | 3.52074197 |
| 87 | renal system process involved in regulation of blood volume (GO:0001977) | 3.51359482 |
| 88 | cellular glucuronidation (GO:0052695) | 3.49422653 |
| 89 | glomerular filtration (GO:0003094) | 3.48256578 |
| 90 | complement activation, classical pathway (GO:0006958) | 3.46795864 |
| 91 | arginine metabolic process (GO:0006525) | 3.46138612 |
| 92 | plasma lipoprotein particle assembly (GO:0034377) | 3.42864528 |
| 93 | antibacterial humoral response (GO:0019731) | 3.41520667 |
| 94 | valine metabolic process (GO:0006573) | 3.40758324 |
| 95 | bile acid and bile salt transport (GO:0015721) | 3.39706574 |
| 96 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.37747797 |
| 97 | cellular response to nitric oxide (GO:0071732) | 3.36065140 |
| 98 | ER-nucleus signaling pathway (GO:0006984) | 3.35089025 |
| 99 | cellular response to topologically incorrect protein (GO:0035967) | 3.31710340 |
| 100 | antimicrobial humoral response (GO:0019730) | 3.28910514 |
| 101 | epithelial structure maintenance (GO:0010669) | 3.28472422 |
| 102 | regulation of vacuole organization (GO:0044088) | 3.26221766 |
| 103 | leukotriene biosynthetic process (GO:0019370) | 3.24514081 |
| 104 | leukotriene metabolic process (GO:0006691) | 3.24341301 |
| 105 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.23412054 |
| 106 | eosinophil chemotaxis (GO:0048245) | 3.21158355 |
| 107 | vitamin transmembrane transport (GO:0035461) | 3.19885031 |
| 108 | coenzyme catabolic process (GO:0009109) | 3.19355401 |
| 109 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.18445976 |
| 110 | renal filtration (GO:0097205) | 3.15095931 |
| 111 | branched-chain amino acid catabolic process (GO:0009083) | 3.14436411 |
| 112 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.13931352 |
| 113 | GDP-mannose metabolic process (GO:0019673) | 3.13198801 |
| 114 | protein-lipid complex assembly (GO:0065005) | 3.12765916 |
| 115 | vitamin transport (GO:0051180) | 3.12688407 |
| 116 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.08619551 |
| 117 | serine family amino acid biosynthetic process (GO:0009070) | 3.07739997 |
| 118 | regulation of respiratory burst (GO:0060263) | 3.07251875 |
| 119 | lipoprotein metabolic process (GO:0042157) | 3.07048099 |
| 120 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.06225611 |
| 121 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.05301733 |
| 122 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.02057719 |
| 123 | cGMP-mediated signaling (GO:0019934) | 3.02027370 |
| 124 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.00894134 |
| 125 | low-density lipoprotein particle remodeling (GO:0034374) | 3.00867236 |
| 126 | killing of cells of other organism (GO:0031640) | 2.99625476 |
| 127 | disruption of cells of other organism (GO:0044364) | 2.99625476 |
| 128 | cellular response to reactive nitrogen species (GO:1902170) | 2.98175408 |
| 129 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.98022439 |
| 130 | sphingolipid catabolic process (GO:0030149) | 2.97982620 |
| 131 | cellular response to cadmium ion (GO:0071276) | 2.97156812 |
| 132 | sulfur amino acid catabolic process (GO:0000098) | 2.96444707 |
| 133 | steroid catabolic process (GO:0006706) | 2.95901431 |
| 134 | sexual reproduction (GO:0019953) | 2.94272732 |
| 135 | peptide hormone processing (GO:0016486) | 2.93663828 |
| 136 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.92471320 |
| 137 | maintenance of protein localization in organelle (GO:0072595) | 2.92448763 |
| 138 | positive regulation of cGMP metabolic process (GO:0030825) | 2.92166788 |
| 139 | regulation of digestive system process (GO:0044058) | 2.91898235 |
| 140 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.90457255 |
| 141 | response to unfolded protein (GO:0006986) | 2.90078148 |
| 142 | ethanol oxidation (GO:0006069) | 2.90024536 |
| 143 | regulation of cholesterol homeostasis (GO:2000188) | 2.88996032 |
| 144 | NADH metabolic process (GO:0006734) | 2.88689746 |
| 145 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.86856878 |
| 146 | positive regulation of antigen processing and presentation (GO:0002579) | 2.86782812 |
| 147 | ER overload response (GO:0006983) | 2.86136114 |
| 148 | midgut development (GO:0007494) | 2.85696015 |
| 149 | branched-chain amino acid metabolic process (GO:0009081) | 2.84733723 |
| 150 | proline metabolic process (GO:0006560) | 2.82731420 |
| 151 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.81921177 |
| 152 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.79428516 |
| 153 | regulation of fever generation (GO:0031620) | 2.78693389 |
| 154 | response to topologically incorrect protein (GO:0035966) | 2.77718563 |
| 155 | glandular epithelial cell differentiation (GO:0002067) | 2.77159692 |
| 156 | peptidyl-asparagine modification (GO:0018196) | 2.77073543 |
| 157 | mucosal immune response (GO:0002385) | 2.76850214 |
| 158 | glucose 6-phosphate metabolic process (GO:0051156) | 2.75461823 |
| 159 | positive regulation of heat generation (GO:0031652) | 2.74939753 |
| 160 | creatine metabolic process (GO:0006600) | 2.72557708 |
| 161 | alkaloid metabolic process (GO:0009820) | 2.70578967 |
| 162 | innate immune response in mucosa (GO:0002227) | 2.68781277 |
| 163 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.68353681 |
| 164 | sulfation (GO:0051923) | 2.68184124 |
| 165 | aspartate family amino acid catabolic process (GO:0009068) | 2.65507587 |
| 166 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.64815462 |
| 167 | L-phenylalanine catabolic process (GO:0006559) | 2.64815462 |
| 168 | cytidine deamination (GO:0009972) | 2.64633018 |
| 169 | cytidine metabolic process (GO:0046087) | 2.64633018 |
| 170 | cytidine catabolic process (GO:0006216) | 2.64633018 |
| 171 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.61793925 |
| 172 | glutamine metabolic process (GO:0006541) | 2.61221565 |
| 173 | negative regulation of macroautophagy (GO:0016242) | 2.60944655 |
| 174 | organ or tissue specific immune response (GO:0002251) | 2.60687434 |
| 175 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.59825879 |
| 176 | intestinal cholesterol absorption (GO:0030299) | 19.4124869 |
| 177 | digestion (GO:0007586) | 11.8381875 |
| 178 | intestinal absorption (GO:0050892) | 11.2594529 |
| 179 | exocrine pancreas development (GO:0031017) | 10.7173710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.20112408 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.06799611 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.58446708 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.48239956 |
| 5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.39105896 |
| 6 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.38300041 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.20729110 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.13524831 |
| 9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.12531142 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00524057 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.90643156 |
| 12 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.84167082 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.63568196 |
| 14 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.47807715 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.44745882 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38642844 |
| 17 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.38504682 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29103379 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.24453130 |
| 20 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.19880221 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.18469829 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.18222448 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.06588641 |
| 24 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.91735620 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79344197 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.76482876 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.70835398 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68927317 |
| 29 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.68630323 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67151983 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56827685 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56766865 |
| 33 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.56378964 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52742892 |
| 35 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.51379726 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.45388500 |
| 37 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.44018103 |
| 38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43775010 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43168568 |
| 40 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41861093 |
| 41 | ATF3_27146783_Chip-Seq_COLON_Human | 1.41625801 |
| 42 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.41414431 |
| 43 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.40739668 |
| 44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38947631 |
| 45 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.36658264 |
| 46 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.35178613 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.34614742 |
| 48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33363886 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32791258 |
| 50 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.32115154 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30665209 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.30072812 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27386523 |
| 54 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.26973497 |
| 55 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.25215763 |
| 56 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.22130124 |
| 57 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20798465 |
| 58 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.19032384 |
| 59 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.18426269 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18285828 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16267957 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15778957 |
| 63 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.15374313 |
| 64 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.13623486 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.13550046 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13506171 |
| 67 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13176658 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12234032 |
| 69 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.12038335 |
| 70 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.11041907 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10200173 |
| 72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09834967 |
| 73 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.09298685 |
| 74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08030468 |
| 75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06452410 |
| 76 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06122735 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05922367 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05445185 |
| 79 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 1.04100717 |
| 80 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.03793916 |
| 81 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02515105 |
| 82 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02496036 |
| 83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01978538 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01317016 |
| 85 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99422007 |
| 86 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98380010 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98226353 |
| 88 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.97371872 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97078656 |
| 90 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95798230 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95553340 |
| 92 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95280892 |
| 93 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94377371 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91892487 |
| 95 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91587157 |
| 96 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.91454258 |
| 97 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90799424 |
| 98 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.90324917 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90318139 |
| 100 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.89786974 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89121141 |
| 102 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88894588 |
| 103 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.88771615 |
| 104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88516476 |
| 105 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.87980586 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87839701 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87562606 |
| 108 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.86463676 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86098400 |
| 110 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85889197 |
| 111 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.85550188 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85377230 |
| 113 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.85355818 |
| 114 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.84882089 |
| 115 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84308231 |
| 116 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84191286 |
| 117 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83930352 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83921442 |
| 119 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83729162 |
| 120 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.83606962 |
| 121 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83014447 |
| 122 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.82572651 |
| 123 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82468031 |
| 124 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.81138847 |
| 125 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.78756575 |
| 126 | KDM2B_26808549_Chip-Seq_K562_Human | 0.78340767 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77688380 |
| 128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77678819 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77449619 |
| 130 | P300_27268052_Chip-Seq_Bcells_Human | 0.76440356 |
| 131 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.75986877 |
| 132 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75879691 |
| 133 | ERA_21632823_ChIP-Seq_H3396_Human | 0.73882891 |
| 134 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.73755411 |
| 135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73331089 |
| 136 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.73018768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001666_abnormal_nutrient_absorption | 9.57260918 |
| 2 | MP0005083_abnormal_biliary_tract | 5.93010491 |
| 3 | MP0005365_abnormal_bile_salt | 5.86293873 |
| 4 | MP0003868_abnormal_feces_composition | 4.98815713 |
| 5 | MP0005220_abnormal_exocrine_pancreas | 4.29005404 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 4.02628527 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.80369143 |
| 8 | MP0009379_abnormal_foot_pigmentation | 3.68587623 |
| 9 | MP0005360_urolithiasis | 3.68467168 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 3.62325442 |
| 11 | MP0003283_abnormal_digestive_organ | 2.93482107 |
| 12 | MP0004264_abnormal_extraembryonic_tissu | 2.76936906 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.65184574 |
| 14 | MP0002693_abnormal_pancreas_physiology | 2.54798938 |
| 15 | MP0004147_increased_porphyrin_level | 2.50915899 |
| 16 | MP0003959_abnormal_lean_body | 2.23734291 |
| 17 | MP0001664_abnormal_digestion | 2.22956426 |
| 18 | MP0003252_abnormal_bile_duct | 2.06111167 |
| 19 | MP0005448_abnormal_energy_balance | 2.03806019 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.02824769 |
| 21 | MP0005409_darkened_coat_color | 1.93974249 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.89309560 |
| 23 | MP0004858_abnormal_nervous_system | 1.85444613 |
| 24 | MP0005166_decreased_susceptibility_to | 1.80904426 |
| 25 | MP0001944_abnormal_pancreas_morphology | 1.69154742 |
| 26 | MP0003638_abnormal_response/metabolism_ | 1.65018982 |
| 27 | MP0005165_increased_susceptibility_to | 1.63160986 |
| 28 | MP0000462_abnormal_digestive_system | 1.58415639 |
| 29 | MP0004782_abnormal_surfactant_physiolog | 1.54903598 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.50253583 |
| 31 | MP0009840_abnormal_foam_cell | 1.50226339 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.42538670 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.36823889 |
| 34 | MP0003724_increased_susceptibility_to | 1.28031051 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.24795909 |
| 36 | MP0004043_abnormal_pH_regulation | 1.24791038 |
| 37 | MP0005451_abnormal_body_composition | 1.21297000 |
| 38 | MP0002078_abnormal_glucose_homeostasis | 1.20447785 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.20294350 |
| 40 | MP0002136_abnormal_kidney_physiology | 1.16835160 |
| 41 | MP0003436_decreased_susceptibility_to | 1.16593940 |
| 42 | MP0005332_abnormal_amino_acid | 1.15709768 |
| 43 | MP0001188_hyperpigmentation | 1.15048563 |
| 44 | MP0003866_abnormal_defecation | 1.12380153 |
| 45 | MP0000490_abnormal_crypts_of | 1.11184978 |
| 46 | MP0003879_abnormal_hair_cell | 1.09442263 |
| 47 | MP0002234_abnormal_pharynx_morphology | 1.08720233 |
| 48 | MP0009785_altered_susceptibility_to | 1.07192472 |
| 49 | MP0005381_digestive/alimentary_phenotyp | 1.06871304 |
| 50 | MP0001663_abnormal_digestive_system | 1.06869690 |
| 51 | MP0001790_abnormal_immune_system | 1.06378380 |
| 52 | MP0005387_immune_system_phenotype | 1.06378380 |
| 53 | MP0001835_abnormal_antigen_presentation | 1.05134034 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.03936094 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.01820347 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.00977281 |
| 57 | MP0004270_analgesia | 1.00920806 |
| 58 | MP0006054_spinal_hemorrhage | 0.99477274 |
| 59 | MP0004019_abnormal_vitamin_homeostasis | 0.98325392 |
| 60 | MP0005025_abnormal_response_to | 0.97921476 |
| 61 | MP0003300_gastrointestinal_ulcer | 0.94919984 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 0.93445038 |
| 63 | MP0001873_stomach_inflammation | 0.92493631 |
| 64 | MP0003329_amyloid_beta_deposits | 0.92185369 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90891280 |
| 66 | MP0003953_abnormal_hormone_level | 0.89350440 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 0.88722105 |
| 68 | MP0005670_abnormal_white_adipose | 0.87370523 |
| 69 | MP0003718_maternal_effect | 0.84681856 |
| 70 | MP0008469_abnormal_protein_level | 0.84186266 |
| 71 | MP0000604_amyloidosis | 0.83449055 |
| 72 | MP0002971_abnormal_brown_adipose | 0.82843289 |
| 73 | MP0006082_CNS_inflammation | 0.82100726 |
| 74 | MP0000613_abnormal_salivary_gland | 0.81312279 |
| 75 | MP0000609_abnormal_liver_physiology | 0.80373049 |
| 76 | MP0010155_abnormal_intestine_physiology | 0.77978006 |
| 77 | MP0000470_abnormal_stomach_morphology | 0.77754057 |
| 78 | MP0005671_abnormal_response_to | 0.77052935 |
| 79 | MP0003303_peritoneal_inflammation | 0.76950657 |
| 80 | MP0000003_abnormal_adipose_tissue | 0.76828878 |
| 81 | MP0005058_abnormal_lysosome_morphology | 0.76803781 |
| 82 | MP0008789_abnormal_olfactory_epithelium | 0.76347812 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.75501619 |
| 84 | MP0001533_abnormal_skeleton_physiology | 0.74701634 |
| 85 | MP0002796_impaired_skin_barrier | 0.74681300 |
| 86 | MP0003045_fibrosis | 0.73306493 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.72801833 |
| 88 | MP0005535_abnormal_body_temperature | 0.71859372 |
| 89 | MP0002098_abnormal_vibrissa_morphology | 0.71780800 |
| 90 | MP0002909_abnormal_adrenal_gland | 0.71313380 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.70800408 |
| 92 | MP0000685_abnormal_immune_system | 0.70426803 |
| 93 | MP0004233_abnormal_muscle_weight | 0.69981063 |
| 94 | MP0005408_hypopigmentation | 0.69615517 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.69548890 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.68057268 |
| 97 | MP0009764_decreased_sensitivity_to | 0.67682938 |
| 98 | MP0002896_abnormal_bone_mineralization | 0.67604208 |
| 99 | MP0009115_abnormal_fat_cell | 0.67055228 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.66512337 |
| 101 | MP0002148_abnormal_hypersensitivity_rea | 0.66034098 |
| 102 | MP0000681_abnormal_thyroid_gland | 0.65480562 |
| 103 | MP0005375_adipose_tissue_phenotype | 0.65340050 |
| 104 | MP0000477_abnormal_intestine_morphology | 0.64994452 |
| 105 | MP0009333_abnormal_splenocyte_physiolog | 0.64804621 |
| 106 | MP0010678_abnormal_skin_adnexa | 0.63814654 |
| 107 | MP0002006_tumorigenesis | 0.62806536 |
| 108 | MP0000249_abnormal_blood_vessel | 0.61989446 |
| 109 | MP0003075_altered_response_to | 0.60473933 |
| 110 | MP0001800_abnormal_humoral_immune | 0.60177394 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.59683016 |
| 112 | MP0005499_abnormal_olfactory_system | 0.59545048 |
| 113 | MP0005394_taste/olfaction_phenotype | 0.59545048 |
| 114 | MP0001756_abnormal_urination | 0.59135423 |
| 115 | MP0001881_abnormal_mammary_gland | 0.58629023 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.58555625 |
| 117 | MP0002089_abnormal_postnatal_growth/wei | 0.58176716 |
| 118 | MP0005000_abnormal_immune_tolerance | 0.57853818 |
| 119 | MP0000598_abnormal_liver_morphology | 0.54718739 |
| 120 | MP0002138_abnormal_hepatobiliary_system | 0.53647164 |
| 121 | MP0008004_abnormal_stomach_pH | 0.53180113 |
| 122 | MP0009053_abnormal_anal_canal | 0.51955466 |
| 123 | MP0005334_abnormal_fat_pad | 0.51694537 |
| 124 | MP0003191_abnormal_cellular_cholesterol | 0.51634567 |
| 125 | MP0000538_abnormal_urinary_bladder | 0.51299882 |
| 126 | MP0009642_abnormal_blood_homeostasis | 0.50063726 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.49021695 |
| 128 | MP0005452_abnormal_adipose_tissue | 0.48625854 |
| 129 | MP0010386_abnormal_urinary_bladder | 0.48557893 |
| 130 | MP0001764_abnormal_homeostasis | 0.46801863 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.45198175 |
| 132 | MP0000537_abnormal_urethra_morphology | 0.43460774 |
| 133 | MP0003566_abnormal_cell_adhesion | 0.43347259 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.41446121 |
| 135 | MP0002877_abnormal_melanocyte_morpholog | 0.41293601 |
| 136 | MP0008872_abnormal_physiological_respon | 0.39900647 |
| 137 | MP0000377_abnormal_hair_follicle | 0.39847517 |
| 138 | MP0003795_abnormal_bone_structure | 0.39104534 |
| 139 | MP0002822_catalepsy | 0.38718537 |
| 140 | MP0009384_cardiac_valve_regurgitation | 0.38401078 |
| 141 | MP0002069_abnormal_eating/drinking_beha | 0.38036060 |
| 142 | MP0010352_gastrointestinal_tract_polyps | 0.37188983 |
| 143 | MP0000678_abnormal_parathyroid_gland | 0.35718861 |
| 144 | MP0002876_abnormal_thyroid_physiology | 0.35626123 |
| 145 | MP0004947_skin_inflammation | 0.34659028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat malabsorption (HP:0002630) | 7.28808374 |
| 2 | Steatorrhea (HP:0002570) | 6.88549803 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 5.44291202 |
| 4 | Chronic diarrhea (HP:0002028) | 5.07478963 |
| 5 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.83693477 |
| 6 | Abnormality of vitamin B metabolism (HP:0004340) | 4.54847594 |
| 7 | Exocrine pancreatic insufficiency (HP:0001738) | 4.43324772 |
| 8 | Flat acetabular roof (HP:0003180) | 4.11667726 |
| 9 | Widely patent fontanelles and sutures (HP:0004492) | 3.97713265 |
| 10 | Gout (HP:0001997) | 3.95401759 |
| 11 | Ketoacidosis (HP:0001993) | 3.88161025 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74938146 |
| 13 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.68850277 |
| 14 | Confusion (HP:0001289) | 3.64966405 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.62894489 |
| 16 | Abnormality of vitamin metabolism (HP:0100508) | 3.61314816 |
| 17 | Posterior subcapsular cataract (HP:0007787) | 3.59594681 |
| 18 | Hypoglycemic seizures (HP:0002173) | 3.58533427 |
| 19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.55060441 |
| 20 | Pancreatitis (HP:0001733) | 3.52056006 |
| 21 | Late onset (HP:0003584) | 3.51069106 |
| 22 | Nausea (HP:0002018) | 3.49791425 |
| 23 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.47188227 |
| 24 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.47188227 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.46739478 |
| 26 | Congenital sensorineural hearing impairment (HP:0008527) | 3.42546831 |
| 27 | Abdominal distention (HP:0003270) | 3.36477100 |
| 28 | Abnormal pancreas size (HP:0012094) | 3.22412564 |
| 29 | Glomerulonephritis (HP:0000099) | 3.21877366 |
| 30 | Proximal tubulopathy (HP:0000114) | 3.19546392 |
| 31 | Ketosis (HP:0001946) | 3.18833977 |
| 32 | Flattened epiphyses (HP:0003071) | 3.17650295 |
| 33 | Pigmentary retinal degeneration (HP:0001146) | 3.17378536 |
| 34 | Decreased circulating renin level (HP:0003351) | 3.09804882 |
| 35 | Abnormal tarsal ossification (HP:0008369) | 3.08103532 |
| 36 | Symptomatic seizures (HP:0011145) | 3.02455086 |
| 37 | Eczematoid dermatitis (HP:0000976) | 3.00214043 |
| 38 | Wide cranial sutures (HP:0010537) | 2.98834991 |
| 39 | Thin bony cortex (HP:0002753) | 2.97385165 |
| 40 | Abnormality of complement system (HP:0005339) | 2.91117663 |
| 41 | Ileus (HP:0002595) | 2.90059074 |
| 42 | Nephrolithiasis (HP:0000787) | 2.87442147 |
| 43 | Villous atrophy (HP:0011473) | 2.86932217 |
| 44 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.86932217 |
| 45 | Complement deficiency (HP:0004431) | 2.86777824 |
| 46 | Alkalosis (HP:0001948) | 2.84168248 |
| 47 | Hypophosphatemia (HP:0002148) | 2.83972620 |
| 48 | Hyperparathyroidism (HP:0000843) | 2.82882812 |
| 49 | Facial shape deformation (HP:0011334) | 2.82689516 |
| 50 | Potter facies (HP:0002009) | 2.82689516 |
| 51 | Cupped ribs (HP:0000887) | 2.82115526 |
| 52 | Hyperglycinuria (HP:0003108) | 2.80719755 |
| 53 | Decreased subcutaneous fat (HP:0001002) | 2.79150368 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.75637084 |
| 55 | Metabolic alkalosis (HP:0200114) | 2.75497462 |
| 56 | Flat capital femoral epiphysis (HP:0003370) | 2.72096041 |
| 57 | Short chin (HP:0000331) | 2.69300713 |
| 58 | Type I diabetes mellitus (HP:0100651) | 2.69257639 |
| 59 | Hyperglycemia (HP:0003074) | 2.67005694 |
| 60 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.65871500 |
| 61 | Hypoproteinemia (HP:0003075) | 2.63941410 |
| 62 | Intrahepatic cholestasis (HP:0001406) | 2.61911922 |
| 63 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.61696973 |
| 64 | Malnutrition (HP:0004395) | 2.60675685 |
| 65 | Hyperammonemia (HP:0001987) | 2.58648118 |
| 66 | Nephritis (HP:0000123) | 2.57591483 |
| 67 | Hypobetalipoproteinemia (HP:0003563) | 2.57205302 |
| 68 | Hypoplasia of the pons (HP:0012110) | 2.53909639 |
| 69 | Megaloblastic anemia (HP:0001889) | 2.53474834 |
| 70 | Hyperphosphatemia (HP:0002905) | 2.52381568 |
| 71 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51216147 |
| 72 | Abnormal cartilage morphology (HP:0002763) | 2.50460930 |
| 73 | Cortical dysplasia (HP:0002539) | 2.49160325 |
| 74 | Abnormal foot bone ossification (HP:0010675) | 2.47154757 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43182887 |
| 76 | Acanthocytosis (HP:0001927) | 2.41305086 |
| 77 | Hypotension (HP:0002615) | 2.40735501 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.40456661 |
| 79 | Hyperactive renin-angiotensin system (HP:0000841) | 2.39846122 |
| 80 | Abnormality of renin-angiotensin system (HP:0000847) | 2.37729409 |
| 81 | Abnormality of purine metabolism (HP:0004352) | 2.34835888 |
| 82 | Abnormality of the pons (HP:0007361) | 2.32641125 |
| 83 | Carpal bone hypoplasia (HP:0001498) | 2.32581072 |
| 84 | Hyperphosphaturia (HP:0003109) | 2.32575942 |
| 85 | Abnormal urine phosphate concentration (HP:0012599) | 2.31807384 |
| 86 | Hemorrhage of the eye (HP:0011885) | 2.29791240 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 2.26453761 |
| 88 | Glycosuria (HP:0003076) | 2.26453761 |
| 89 | Micronodular cirrhosis (HP:0001413) | 2.24816054 |
| 90 | Abnormality of nucleobase metabolism (HP:0010932) | 2.24135933 |
| 91 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.23182893 |
| 92 | Abnormality of glycine metabolism (HP:0010895) | 2.23182893 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 2.22041549 |
| 94 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22041549 |
| 95 | Hyperuricemia (HP:0002149) | 2.18547559 |
| 96 | Increased purine levels (HP:0004368) | 2.18547559 |
| 97 | Spinal cord compression (HP:0002176) | 2.17053345 |
| 98 | Focal segmental glomerulosclerosis (HP:0000097) | 2.16378801 |
| 99 | Limb hypertonia (HP:0002509) | 2.15321612 |
| 100 | Cerebral palsy (HP:0100021) | 2.14936414 |
| 101 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.14475898 |
| 102 | Barrel-shaped chest (HP:0001552) | 2.12776557 |
| 103 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.12669799 |
| 104 | Abnormal glucose tolerance (HP:0001952) | 2.12486296 |
| 105 | Vacuolated lymphocytes (HP:0001922) | 2.11891237 |
| 106 | Ventricular fibrillation (HP:0001663) | 2.10626953 |
| 107 | Growth hormone excess (HP:0000845) | 2.09306277 |
| 108 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.05167619 |
| 109 | Gingivitis (HP:0000230) | 2.04851489 |
| 110 | Progressive sensorineural hearing impairment (HP:0000408) | 2.03379011 |
| 111 | Severe short stature (HP:0003510) | 2.03089178 |
| 112 | Xanthomatosis (HP:0000991) | 2.02507885 |
| 113 | Subcapsular cataract (HP:0000523) | 2.02132414 |
| 114 | Gastrointestinal dysmotility (HP:0002579) | 2.02118769 |
| 115 | Enlarged epiphyses (HP:0010580) | 2.01955579 |
| 116 | Vertebral clefting (HP:0008428) | 2.01783901 |
| 117 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.01452308 |
| 118 | Hypolipoproteinemia (HP:0010981) | 1.98618867 |
| 119 | Metabolic acidosis (HP:0001942) | 1.98476514 |
| 120 | Esophageal varix (HP:0002040) | 1.97555305 |
| 121 | Hyperglycinemia (HP:0002154) | 1.97040098 |
| 122 | Protuberant abdomen (HP:0001538) | 1.96799972 |
| 123 | Irregular epiphyses (HP:0010582) | 1.96417229 |
| 124 | Premature skin wrinkling (HP:0100678) | 1.94457513 |
| 125 | Neonatal short-limb short stature (HP:0008921) | 1.93547421 |
| 126 | Maternal diabetes (HP:0009800) | 1.93001131 |
| 127 | Renal tubular acidosis (HP:0001947) | 1.92866541 |
| 128 | Abnormality of the costochondral junction (HP:0000919) | 1.92168609 |
| 129 | Insulin resistance (HP:0000855) | 1.91640790 |
| 130 | Vertebral hypoplasia (HP:0008417) | 1.91591082 |
| 131 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.91591082 |
| 132 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91450789 |
| 133 | Mucopolysacchariduria (HP:0008155) | 1.91450789 |
| 134 | Abnormality of magnesium homeostasis (HP:0004921) | 1.90408587 |
| 135 | Prolonged QT interval (HP:0001657) | 1.89990512 |
| 136 | Hypsarrhythmia (HP:0002521) | 1.89882928 |
| 137 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.89781425 |
| 138 | Fatigue (HP:0012378) | 1.89206294 |
| 139 | Delayed epiphyseal ossification (HP:0002663) | 1.87990908 |
| 140 | Hydroxyprolinuria (HP:0003080) | 1.87509395 |
| 141 | Abnormality of proline metabolism (HP:0010907) | 1.87509395 |
| 142 | Large for gestational age (HP:0001520) | 1.85774473 |
| 143 | Acute hepatic failure (HP:0006554) | 1.85489142 |
| 144 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85141187 |
| 145 | Gastrointestinal stroma tumor (HP:0100723) | 1.84850695 |
| 146 | Progressive hearing impairment (HP:0001730) | 1.84705803 |
| 147 | EEG with generalized epileptiform discharges (HP:0011198) | 1.82046588 |
| 148 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.80982273 |
| 149 | Abnormal protein glycosylation (HP:0012346) | 1.80608446 |
| 150 | Abnormal glycosylation (HP:0012345) | 1.80608446 |
| 151 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.80608446 |
| 152 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.80608446 |
| 153 | Abnormal vertebral ossification (HP:0100569) | 1.80351567 |
| 154 | Abnormal biliary tract morphology (HP:0012440) | 1.78151716 |
| 155 | Syncope (HP:0001279) | 1.77435168 |
| 156 | Hypoalbuminemia (HP:0003073) | 1.76335192 |
| 157 | Abnormal albumin level (HP:0012116) | 1.76335192 |
| 158 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.76222970 |
| 159 | Irritability (HP:0000737) | 1.76125684 |
| 160 | Emphysema (HP:0002097) | 1.73934657 |
| 161 | Epidermoid cyst (HP:0200040) | 1.71975788 |
| 162 | Multiple lipomas (HP:0001012) | 1.71490384 |
| 163 | Hypocalcemia (HP:0002901) | 1.71274925 |
| 164 | Bone cyst (HP:0012062) | 1.71113006 |
| 165 | Petechiae (HP:0000967) | 1.71001341 |
| 166 | Pili torti (HP:0003777) | 1.69518883 |
| 167 | Skin rash (HP:0000988) | 1.69288490 |
| 168 | Glomerulosclerosis (HP:0000096) | 1.69039457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 9.59672018 |
| 2 | ACVR1B | 6.46564232 |
| 3 | BCKDK | 4.84500627 |
| 4 | FRK | 4.38733564 |
| 5 | MAP2K2 | 4.05690557 |
| 6 | ERN1 | 3.66966210 |
| 7 | TRIB3 | 2.66469826 |
| 8 | EIF2AK3 | 2.60282969 |
| 9 | FGFR4 | 2.56566320 |
| 10 | INSRR | 2.45620065 |
| 11 | EPHB2 | 2.34947167 |
| 12 | PKN2 | 2.20114028 |
| 13 | TYK2 | 2.19227700 |
| 14 | NME1 | 2.18664438 |
| 15 | MAP3K2 | 1.93897506 |
| 16 | OXSR1 | 1.91678262 |
| 17 | PTK6 | 1.89261009 |
| 18 | MAP3K12 | 1.76678330 |
| 19 | MAP4K1 | 1.67360109 |
| 20 | MAP2K1 | 1.66745456 |
| 21 | TESK2 | 1.58006837 |
| 22 | MAPK15 | 1.49197776 |
| 23 | EPHA2 | 1.48452833 |
| 24 | STK24 | 1.47991623 |
| 25 | RIPK1 | 1.39175055 |
| 26 | MYLK | 1.34223131 |
| 27 | FGFR3 | 1.30792001 |
| 28 | PRPF4B | 1.26877291 |
| 29 | RIPK4 | 1.23959738 |
| 30 | FLT3 | 1.23387149 |
| 31 | SCYL2 | 1.17835951 |
| 32 | NLK | 1.17088377 |
| 33 | MST1R | 1.15825326 |
| 34 | KSR2 | 1.15432625 |
| 35 | IRAK3 | 1.10199513 |
| 36 | GRK6 | 1.09712477 |
| 37 | MAPKAPK3 | 1.03961958 |
| 38 | LMTK2 | 1.03638037 |
| 39 | LATS1 | 1.02959827 |
| 40 | RPS6KB2 | 0.96588888 |
| 41 | TNIK | 0.95380856 |
| 42 | WNK4 | 0.95142464 |
| 43 | ZAP70 | 0.94317226 |
| 44 | MAP3K9 | 0.93430240 |
| 45 | JAK1 | 0.93237357 |
| 46 | PRKG2 | 0.91061730 |
| 47 | PAK2 | 0.91008686 |
| 48 | PIK3CA | 0.89435089 |
| 49 | PTK2 | 0.87698132 |
| 50 | MAP3K1 | 0.86622612 |
| 51 | TAOK1 | 0.86553048 |
| 52 | IRAK1 | 0.85369186 |
| 53 | MAP3K11 | 0.84018825 |
| 54 | MET | 0.83295450 |
| 55 | NTRK1 | 0.79209140 |
| 56 | CAMKK1 | 0.79122028 |
| 57 | IKBKE | 0.78558554 |
| 58 | DYRK1A | 0.76538319 |
| 59 | MST4 | 0.66434594 |
| 60 | EEF2K | 0.65243066 |
| 61 | MAP2K6 | 0.64434613 |
| 62 | BMPR2 | 0.63727266 |
| 63 | CDK19 | 0.62784425 |
| 64 | ILK | 0.62202764 |
| 65 | EPHA4 | 0.61571793 |
| 66 | JAK3 | 0.60988973 |
| 67 | GRK1 | 0.60307765 |
| 68 | KIT | 0.60214886 |
| 69 | PDGFRB | 0.57137868 |
| 70 | PRKD3 | 0.56746217 |
| 71 | PDGFRA | 0.54787815 |
| 72 | FER | 0.54610318 |
| 73 | RET | 0.53999284 |
| 74 | TGFBR2 | 0.52094554 |
| 75 | DYRK1B | 0.47212855 |
| 76 | SRC | 0.46424869 |
| 77 | CSF1R | 0.45956129 |
| 78 | PIK3CG | 0.45503035 |
| 79 | PDPK1 | 0.44457527 |
| 80 | PRKCI | 0.44389045 |
| 81 | BMX | 0.43851760 |
| 82 | HIPK2 | 0.43460224 |
| 83 | CAMKK2 | 0.43104427 |
| 84 | ICK | 0.42124246 |
| 85 | FYN | 0.41799963 |
| 86 | NUAK1 | 0.41357530 |
| 87 | EPHB1 | 0.40936558 |
| 88 | PASK | 0.39744057 |
| 89 | MAPK11 | 0.39428419 |
| 90 | PAK4 | 0.38516301 |
| 91 | CASK | 0.38279458 |
| 92 | PRKCD | 0.37939416 |
| 93 | STK39 | 0.37729715 |
| 94 | PDK1 | 0.37700047 |
| 95 | IRAK4 | 0.37457361 |
| 96 | PDK2 | 0.37418135 |
| 97 | ABL2 | 0.37077986 |
| 98 | PRKCH | 0.36932210 |
| 99 | NME2 | 0.36026073 |
| 100 | LRRK2 | 0.36017126 |
| 101 | YES1 | 0.35411976 |
| 102 | BTK | 0.35083654 |
| 103 | PRKCZ | 0.34941129 |
| 104 | SYK | 0.33958384 |
| 105 | EPHA3 | 0.33749408 |
| 106 | LYN | 0.33079147 |
| 107 | AKT3 | 0.32991623 |
| 108 | PRKCQ | 0.32911354 |
| 109 | MAP3K7 | 0.32384597 |
| 110 | BLK | 0.32174193 |
| 111 | CAMK2D | 0.31676213 |
| 112 | JAK2 | 0.30326790 |
| 113 | MTOR | 0.30246461 |
| 114 | NTRK3 | 0.30237922 |
| 115 | CAMK2G | 0.29651091 |
| 116 | MAP3K8 | 0.28784885 |
| 117 | NEK6 | 0.28722453 |
| 118 | RPS6KB1 | 0.27800839 |
| 119 | TBK1 | 0.27496176 |
| 120 | LCK | 0.26966230 |
| 121 | MAP3K10 | 0.26106332 |
| 122 | PIM1 | 0.25818132 |
| 123 | DMPK | 0.24482436 |
| 124 | CAMK2B | 0.24064445 |
| 125 | MAP3K14 | 0.23323009 |
| 126 | SMG1 | 0.23053088 |
| 127 | MAPK7 | 0.23016234 |
| 128 | IRAK2 | 0.20733366 |
| 129 | DAPK2 | 0.17974436 |
| 130 | PRKD1 | 0.17479673 |
| 131 | MAP3K3 | 0.17475905 |
| 132 | SIK1 | 0.17321483 |
| 133 | TESK1 | 0.17254049 |
| 134 | PRKAA2 | 0.16832239 |
| 135 | ERBB2 | 0.16526995 |
| 136 | DDR2 | 0.16421653 |
| 137 | PRKCA | 0.16216619 |
| 138 | PRKD2 | 0.16189066 |
| 139 | GSK3A | 0.15477674 |
| 140 | CSK | 0.15083567 |
| 141 | PRKAA1 | 0.13600380 |
| 142 | CDC42BPA | 0.13518888 |
| 143 | MATK | 0.12979007 |
| 144 | PRKACG | 0.12253150 |
| 145 | ITK | 0.11458473 |
| 146 | CDK5 | 0.09303761 |
| 147 | IGF1R | 0.09114329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.99695608 |
| 2 | Pancreatic secretion_Homo sapiens_hsa04972 | 6.16633945 |
| 3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 4.38425934 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.96243106 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.71317287 |
| 6 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.65235009 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.64926745 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.62393897 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.54404817 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.27367582 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.08250099 |
| 12 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.03304904 |
| 13 | Asthma_Homo sapiens_hsa05310 | 1.85169901 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.84015967 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.78907959 |
| 16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.69340740 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.64151610 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.52274788 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45098811 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41923989 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.38048657 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33775307 |
| 23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33457017 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.33226379 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30055242 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.28211877 |
| 27 | Mineral absorption_Homo sapiens_hsa04978 | 1.27478755 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.25572716 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22006410 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21270749 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.19367810 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11056917 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05185976 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03006064 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01228579 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.99674146 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 0.96965804 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93204869 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 0.89757928 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88467376 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87494331 |
| 42 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86207757 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84287677 |
| 44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81023570 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79235876 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73273873 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70850121 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70235447 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69425569 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65941213 |
| 51 | Leishmaniasis_Homo sapiens_hsa05140 | 0.65592571 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64976010 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63781859 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62961356 |
| 55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62128750 |
| 56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61243104 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59756253 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58874272 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57823185 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57696482 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55972533 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55538656 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54657007 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51789292 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51581641 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50255702 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49978779 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.49685348 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48288625 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48237731 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 0.47892373 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45546123 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43405571 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42741383 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.40230985 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39804334 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39685198 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38624730 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38319906 |
| 80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.38200184 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36948904 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.36492244 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35304240 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33769191 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33550686 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33093872 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32429798 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32282801 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.32098816 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31590170 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31571095 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31226576 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29850569 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29772358 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.28095295 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27856775 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27581678 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.25462956 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25331278 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24664577 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23732362 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23678228 |
| 103 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23643885 |
| 104 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23437276 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.22756576 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21534985 |
| 107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.20782742 |
| 108 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.20729069 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20373711 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.20155447 |
| 111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.19897159 |
| 112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18634944 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | 0.18435882 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18165294 |
| 115 | Tuberculosis_Homo sapiens_hsa05152 | 0.18147614 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.18085577 |
| 117 | Parkinsons disease_Homo sapiens_hsa05012 | 0.17451399 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.17377246 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.17304484 |
| 120 | Tight junction_Homo sapiens_hsa04530 | 0.16985322 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16863835 |
| 122 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.16777810 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.12235246 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.12231346 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.11966846 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.11663675 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.11233267 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.08489772 |
| 129 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.07381571 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.06986902 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.06843401 |
| 132 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.06467653 |
| 133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.05691909 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.05250734 |
| 135 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.04978520 |
| 136 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.04528645 |
| 137 | Salivary secretion_Homo sapiens_hsa04970 | 0.04142198 |

